Overview

Comparative Pharmacokinetics and Pharmacodynamics of Tiotropium With Ipratropium or Placebo After 19 Days of Tiotropium Treatment

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Comparative Pharmacokinetics and Pharmacodynamics of Tiotropium With Ipratropium or Placebo After 19 Days of Tiotropium Treatment
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Ipratropium
Tiotropium Bromide